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DIFFERENCES IN LOCALIZATION OF P2X7 DURING EPITHELIAL WOUND 
HEALING IN PRE-TYPE II DIABETIC MODELS  
KRISANDRA KNEER 
ABSTRACT 
 Corneal injury, accompanied by improper wound repair, is the 4th highest cause 
of preventable blindness according to the World Health Organization. The cornea, which 
is the most densely innervated structure in the human body, serves to protect the delicate 
internal environment of the eye from damage. The integrity of this intricate nerve 
structure is critical in our ability to sense even the slightest insult to the corneal surface, 
with reduced sensitivity leading to increased susceptibility to trauma. In diabetes, 
decreased corneal sensitivity secondary to diabetic peripheral neuropathy can lead to 
increased corneal abrasion, ulceration, and even blindness. The P2X7 purinoreceptor is 
an ion channel that is expressed by the epithelium along with the intra-epithelial nerves 
and stromal nerves. The goal of our study was to use a type 2 diabetic mouse model 
(DIO) to characterize the changes in P2X7 localization and potentially correlate our 
results with changes in trafficking and sensory nerve loss. We hypothesized that the 
P2X7 receptor acts to sense changes at the leading edge and this fine tuned regulation is 
altered during the diabetic disease state. Further understanding of the corneal changes 
that occur in diabetes can help us better monitor progression of diabetic complications as 
well as develop new therapeutics for the treatment of diabetic corneal dysfunction. 
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INTRODUCTION 
Diabetes is one of the world's greatest health challenges and its prevalence 
appears to be increasing. The number of people with diabetes worldwide has risen from 
108 million in 1980 to 422 million in 2014, a prevalence of 8.5% among the adult 
population (“WHO | Diabetes,” 2016). In the U.S. prevalence is even greater, affecting 
9.4% of the population, with type II diabetes accounting for about 95% of cases 
(“National Diabetes Statistics Report | Data & Statistics | Diabetes | CDC,” 2017). The 
burden of diabetes is characterized by the chronic progressive damage seen in major 
organs. One organ that is affected by diabetes that has historically been underappreciated, 
however, is the most superficial and transparent: the cornea. Previous findings have 
demonstrated the considerable effects of diabetes mellitus (DM) on all the layers of the 
cornea. These studies have documented that the diabetic cornea is vulnerable to many 
abnormalities such as corneal endothelial damage, recurrent corneal erosions, persistent 
epithelial defects, impaired corneal sensitivity, ulcers, slowed wound repair, punctate 
epithelial keratopathy and superficial keratitis (Herse, 1988). Just as retinopathy is a 
marker of micro-vascular disease, corneal nerve and epithelial changes may predict 
peripheral and autonomic neuropathy and also imply more widespread disease. Thus, an 
improved understanding of the ocular surface changes resulting from diabetes has the 
potential to provide earlier biomarkers and facilitate proactive intervention prior to the 
development of more severe complications (Shih, Lam, & Tong, 2017).  
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Overview of the cornea and its innervation 
Structure  
The cornea is a transparent avascular connective tissue that acts as the primary 
infectious and structural barrier of the eye. The outer most layer is a non-keratinized, 
pseudostratified epithelium, an integral part of the tear film–cornea interface critical to 
the refractive power of the eye. Some would say outermost is the tear film underlying the 
outermost epithelial cells are the suprabasal or wing cells that can be 2-3 cells in depth. 
Below the wing cells is the deepest cellular layer known as the basal layer, and is 
comprised of a single cell columnar epithelium. The basal cells are the only cells of the 
epithelium capable of asymmetric mitosis and are attached to the underlying basal 
membrane (DelMonte & Kim, 2011). Posterior to the basal lamina is the thick stroma, 
composed of type I and type V collagen lamellae and proteoglycans, providing the bulk 
of the structural framework and accounting for about 80-85% of corneal thickness (Boote 
et al., 2003). The rigidity of the most anterior part of the corneal stroma is thought to play 
a particularly important role in the maintenance of corneal curvature, dependent on 
hydration and intraocular pressure (Müller, et al., 2001).  
Innervation  
The cornea is one of the most heavily innervated tissues in the human body and 
plays a central role in the maintenance of a healthy ocular surface (Guthoff, et al., 2005; 
He & Bazan, 2016). Though densely innervated, the cornea is completely avascular 
which makes the epithelium an ideal model to study wound healing. The corneal nerve 
fibers are sensory in origin and are derived from the trigeminal nerve. Nerve bundles 
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enter the cornea at the periphery in a radial fashion, parallel to the corneal service, and 
then subdivide several times into smaller side branches. The transparence of the cornea is 
due to the absence of a myelin sheath surrounding the corneal axons. The side branches 
of the stromal nerves eventually turn 90 degrees and proceed towards the corneal surface. 
Once they penetrate the basement membrane, they turn 90 degrees again and run parallel 
to the surface in the basal layer. The final division of nerves turn 90 degrees once more to 
penetrate through the apical surfaces of the epithelium and are known as the epithelial 
leashes (Müller, et al., 2003). Through the release of neurotropic factors such as 
glutamate, substance P, or ATP, these neurons influence protein-signaling cascades that 
occur during a wound response. Glutamate binds to both metabotropic G-protein coupled 
receptors as well as ionotropic class receptors such as N-methyl-D-aspartate (NMDA) 
receptors. Upon injury to the epithelial cells, nucleotides are released at the wound site, 
which then bind to specific purinergic class receptors initiating the wound healing 
response (Ralevic & Burnstock, 1998). 
Epithelial Wound Healing Response   
Rapid epithelial wound healing of the cornea is essential for maintaining the 
homeostasis and function of the tissue and in preventing pathologies that can result in 
chronic erosion and pain. Wound repair involves a number of processes including cell 
adhesion, migration, proliferation, matrix deposition and tissue remodeling, many of 
which are mediated by growth factors, and/or cytokines released in response to injury 
(Werner & Grose, 2003). The early response of epithelial wound healing in the cornea is 
characterized by the release of nucleotides, Ca2+ wave propagation from the wound site 
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along with cytoskeleton rearrangements that promote migration of cells to the wound bed 
lead to reestablish the integrity of the epithelial barrier (Minns, et al., 2016). This process 
is orchestrated by the surrounding neurons that facilitate epithelial cell-cell 
communication (Oswald et al., 2012).   Immediately after injury there is a release of 
nucleotides, including ATP, into the extracellular milieu that are able to trigger a number 
of downstream effects upon degradation through their resulting byproducts (Yin, et al., 
2007). ATP and other nucleotides are thought to undergo rapid enzymatic degradation by 
ectonucleotidases. By potentially controlling the lifespan of these molecules, 
ectonuclotidases control the availability of active metabolites, thus regulating ligand 
activity and receptor activation (Abbracchio, et al., 2009).  Adenosine binds to 
purinoreceptor P1, a G-protein coupled receptor that has inhibitory functions around the 
body, whereas ATP analogues bind to P2 purinoreceptors. There are two families of the 
P2 purinergic receptor family that are activated in response to injury, P2X and P2Y. The 
P2Y receptor are G-protein-coupled receptors that cause an increase in intracellular Ca2+ 
via inositol 1,4,5 triphosphate-mediating signaling, whereas the P2X receptors are ATP-
gated ion channels that gate ions from the extracellular environment (Ralevic & 
Burnstock, 1998). The focus of my thesis will be on the P2X pathway, specifically the 
receptor P2X7. P2X7 is necessary for proper epithelial cell adhesion to the basement 
membrane as well as the overall integrity of the corneal stroma.  Previous research has 
demonstrated P2X7 activation promotes the turnover of focal adhesions at the leading 
edge of corneal epithelial wound healing and is necessary for timely healing of abrasion 
tissue wounds (Mayo, et. al, 2008; Minns et al., 2016). 
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Corneal Epithelial Changes in Diabetics  
Diabetic epithelial problems are often summarily referred to as diabetic 
keratopathy emphasizing the major impact on corneal epithelium. Signs of diabetic 
keratopathy include epithelial fragility, defects and recurrent erosions, non-healing ulcers, 
corneal edema due to altered epithelial barrier function, superficial punctate keratitis, 
abnormally slow and often incomplete wound healing, lower cell density especially in the 
basal layer, and increased susceptibility to injury (Ljubimov, 2017). A positive 
correlation between high glucose levels and deleterious effects on cellular behavior of 
human corneal epithelial cells perhaps via purinergic signaling cascades has been 
previously demonstrated, suggesting a possible causation for the delayed corneal 
epithelial wound healing observed in diabetic keratopathy (Tomomatsu et. al, 2009 &. 
Fujita, et al., 2003). It has also been suggested by a number of studies that corneal 
epithelial changes are manifestations of diabetic neuropathy. 
Peripheral Neuropathy in Diabetics  
It has been demonstrated that patients with diabetes have decreased corneal 
sensitivity and have increased vulnerability to trauma (Nielsen, 1978). This has 
implications for epithelial wound healing since alterations in corneal nerves decrease the 
sensitivity resulting in hypoesthesia that disrupts the epithelial architecture and function. 
The results of a recent study have shown that one of the functions of corneal nerve fibers 
is in maintaining a healthy cornea and promoting wound healing after eye injuries 
(Müller et al., 2003). The results of in vitro studies suggest neurons provide trophic 
support to corneal epithelial cells through the release of neurotransmitters and 
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neuropeptides. These trophic factors facilitate corneal epithelial cell growth, proliferation, 
differentiation, and type VII collagen production. Thus, patients with impaired corneal 
innervation, as demonstrated in diabetes, are at increased risk of corneal damage because 
of diminished trophic support (Garcia-Hirschfeld, Lopez-Briones, & Belmonte, 1994). 
Corneal neuropathy in diabetic models has already been visualized by a number of 
studies through confocal microscopy.  Ueno et al. found a decreased density of the 
corneal sub basal nerve plexus and corneal epithelial branches in a leptin receptor mutant, 
and that the corneal sub basal nerves were more tortuous in these mutant mice than in 
normal mice (Ueno et al., 2014). Another study comparing neuropathy between type I 
and type II diabetes found that diet-induced obesity led to a more rapid development and 
progression of peripheral neuropathy and nerve structural damage in the cornea (Yorek et 
al., 2015). Given impaired corneal innervation in diabetes is an important early indicator 
of diabetic neuropathy, it is important that this relationship between neuropathy, protein 
signaling, and its mitigating effects on wound healing are further investigated.  
Specific Aims   
 This study aims to further characterize the molecular and cellular signaling events 
that are disrupted in diabetic patients. Additionally, as purinergic cascades compose 
major non-synaptic chemical pathways regulating the internal homeostatic neural 
environment, we focus on this class of receptor to better elucidate a mechanism behind 
peripheral neuropathy and its associated attenuated wound healing seen in diabetes. 
Utilizing mouse models, immunohistochemistry techniques and confocal microscopy, we 
aim to analyze and quantify the differences in neuronal and purinergic signaling seen in 
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type II diabetes.   
The specific aims are as follows:  
1. Identify and quantify epithelial P2X7 localization in response to wound 
healing in type II diabetic models  
2. Compare difference in localization with respect to length of time on high 
fat diet  
3. Explore potential role of cis-golgi in relation to P2X7 localization  
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METHODS 
Tissue preparation 
C57BL/6J mice were obtained from Jackson Laboratory at 7.5, 15, and 22 wks of age 
(Bar Harbor, ME). Control mice were maintained on a 10 kcal% high fat diet, while type 
II pre-diabetic diet induced obesity (DIO) mice were administered a 60 kcal% high fat 
chow at Jackson Labs (Jackson Labs, Bar Harbor, ME). Prior to delivery, body weight, 
blood glucose, and glucose tolerance test measurements were obtained from Jackson 
laboratory. Mice were acclimated to remove variability of stress from traveling as 
determined in preliminary experiments. Mice were euthanized and a minimum of 3 
corneas per time point (7.5, 15, and 22 weeks) and condition were analyzed. The research 
protocol conformed to the standards of the Association for Research in Vision and 
Ophthalmology for the Use of Animals in Ophthalmic Care and Vision Research and the 
Boston University IACUC protocol. 
Corneal Abrasions 
 To examine localization of P2X7 in response to wound healing, debridement 
wounds were performed and corneas prepared for organ culture and wound healing 
determined after 6 hr (Lee et al 2014; Minns et al 2016). Briefly, a 1.5-mm epithelial 
debridement wound was made, eyes enucleated, and corneas dissected leaving an intact 
scleral rim. Corneas were inverted, and the endothelial cavity was filled with DMEM 
supplemented with 0.75% low agar. The corneas were righted and placed endothelial-side 
down into 35-mm2 6 well plates and DMEM media (containing 100 /ml penicillin, and 
100 μg/ml streptomycin), was added to just reach the sclera. The tissue was incubated at 
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37°C and 5% CO2. The organ culture maintained the tissue in its proper 3D-environment.  
To determine wound healing curves, corneas were stained with 1% methylene blue in 
phosphate buffered saline (PBS) (pH 7.4) at indicated times after injury (Lee et al., 2014; 
Minns et al., 2016). The corneal tissue used in our quantification of P2X7 expression 
experiments were fixed 6 hours after wounding.  
Immunofluorescence  
Purinergic Receptor P2X7  
 Immunofluorescent staining for purinergic receptor P2X7 was performed as 
described previously (Lee et al 2014; Kehasse, 2014). Corneas were fixed in 4% 
paraformaldehyde and further fixed using an optimized methanol fixation protocol (Stepp 
et. al 2016) (Figure 1). Briefly corneal tissue samples were subjected to a rehydration 
series, with increasing concentrations of Triton X-100 in PBS. Corneas were washed with 
PBS before blocking with 4% bovine serum albumin (BSA) solution for 2 hours. To 
examine localization of P2X7 at the different conditions and ages, corneas were 
incubated in the primary anti-P2X7 E1E8T Rabbit mAb, (1:200) overnight at 4°C, washed 
in PBS containing 0.02% Tween solution for 4 hours, and then incubated in PBS 
containing 4% BSA for 2 hours at room temperature (Cell Signaling Technology, 
Danvers, MA). Corneas were then incubated in anti-rabbit secondary antibody (1:200) for 
2 hours. After staining, the corneal organ cultures were maintained in a vectashield 
glycerol solution with DAPI for long-term storage at 4C (Vector Labs, Burlingame, 
CA).  
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Cis-Golgi Apparatus 
 Immunofluorescent staining for Cis-Golgi was performed using Vector 
Laboratories FMK-2201 M.O.M. Kit for detecting mouse primary antibodies on mouse 
tissue (Burlingame, CA) (Figure 2). Corneas were washed with PBS and Trition-X 
(0.1%) for 20 minutes prior to blocking with the Ig Blocking Reagent created with the 
M.O.M. kit for 1 hour. Following blocking, corneas were then washed in PBS and 
incubated for 10 minutes in stock diluent solution created with the M.O.M. kit. They 
were then incubated in a diluted primary antibody solution utilizing anti-cis-golgi GM130 
Mouse mAb (1:100) for 30 minutes, washed for 30 minutes in PBS, and then incubated in 
Figure 1: Optimized methanol fixation protocol. Methanol fixation protocol was 
optimized to a four-day procedure for P2X7 anti-body staining. Original obtained from 
Dr. Stepp et al., and modified. Further optimization may be necessary for antibodies not 
used in this document. 
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a secondary antibody (1:300) for another 30 minutes (Cell Signaling Technology, 
Danvers, MA). Staining was concluded after 30 minutes of PBS washes and corneal 
organ cultures were maintained in a vectashield glycerol solution without DAPI for long-
term storage at 4°C (Vector Labs, Burlingame, CA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Confocal Microscopy 
 Fluorescent images to examine localization of P2X7 at the wound leading edge 
were obtained in a sagittal cross-section plane of view taken on a Zeiss LSM 700 
Figure 2: Mouse on Mouse Antibody Staining Protocol. Vector Laboratories FMK-
2201 M.O.M. Kit staining protocol that was used for cis-golgi apparatus staining.  
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confocal microscope (Zeiss; Thornwood, NY). Corneas used for these analyses were 
stained as individual wedges for P2X7, with the wedge point containing the corneal 
abrasion injury site. The wedges were propped laterally upright on a glass-bottomed dish, 
with the cross-section plane of view sitting directly flush with the bottom of the dish. The 
40x oil objective at a 0.5x zoom was positioned over the leading edge using the ocular 
viewfinders. The resulting image thus elucidated purinergic receptor localization and 
expression at the wound leading edge in the epithelium as well as the underlying the 
stroma. Each image was taken as a 5 layer z-stack with each layer being 0.360 µm apart, 
with a total z-plane range of 1.44 µm. The pinhole size was kept at 1 Airy Unit across all 
images. Florescent gain levels were set using secondary control samples. Images were 
obtained using ZEN-Black Edition software (Carl Zeiss) and analyzed further using 
FIJI/ImageJ (NIH, Bethesda, MD; http://imagej.nih.gov/ij/).  
 Images obtained of the cis-golgi apparatus were acquired with a Zeiss 880 
confocal microscope using the AIRyScan Super-Resolution function. Corneas for this 
analysis were stained the same day as imaging using the Vector Laboratory Mouse-on-
Mouse antibody protocol. Images were taken with a 63x oil objective at a 2x zoom 
positioned over the tip of the wounded corneal epithelium. The resulting image 
elucidated cis-golgi expression in the epithelial corneal cells. The pinhole size was kept at 
1 Airy Unit for both of the Control and DiO tissue samples analyzed. Florescent gain 
levels were set using secondary control samples. Images were obtained using ZEN-Black 
and analyzed using ZEN 2 lite software (Carl Zeiss).   
 13 
 
Image Analysis 
 Localization of P2X7 was quantified using the FIJI/ImageJ software program 
using a common threshold to minimize background noise and artefactual staining seen in 
the confocal images. Using the polygon selection tool, regions of interest were outlined in 
40µm intervals from 0µm-200µm starting from the leading edge of the wound. The Area 
Fraction of pixels above the set threshold was then measured for each 40µm region 
individually among each layer of the z-stack images allowing for manual determination 
of background noise and artefactual staining (Figure 3). Area fraction values were used to 
account for variance in epithelial thickness between samples, therefore providing a more 
accurate assessment of P2X7 concentration within each region of interest. These 
percentages were then recorded in Excel and averaged across the z-stack layers for each 
40µm interval and were later transferred to GraphPad Prism software for statisitcal 
anaylsis. Qualitative visual representations of Golgi and P2X7 expression were created 
using ZEN 2 lite software’s 2.5D image display feature.   
  
Figure 3: Schematic for analysis of P2X7 Immunohistochemistry  
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 Epithelial and stromal thicknesses of the corneas were analyzed using ImageJ to 
characterize the morphological differences often found in diabetic models. The thickness 
of the epithelial layer (measured as the distance from the apical tip of surface epithelial 
cells to Bowman’s membrane) and the thickness of the stromal layer (from Bowman’s 
layer to Descemet’s membrane) were measured using the straight-line tool drawn 
perpendicular to the tangent of the curve of the corneal surface at a given point. For each 
section, three measurements of epithelial and stromal thickness were taken at different 
points along the section.  
Statistical Analysis  
 Values are mean plus and minus standard error of the mean of at least three 
independent experiments. Statistical significance was determined by unpaired, one-tailed 
Student’s t-test or two-way ANOVA with Bonferroni post hoc test using GraphPad Prism 
5 (GraphPad Software, San Diego, CA).  
Real-Time PCR 
 RNA was isolated from epithelium and stroma of mice exposed to a high fat diet 
for 15 weeks. Tissue was placed into ice-cold PBS, spun cells down at low speed to 
prevent lysing (~2,000 rpm), and the precipitate resuspended in RNA lysis buffer (Minns 
et al 2016).  Cells were homogenized to ensure complete lysis with a Polytron 
homogenizer. mRNA was isolated using the RNEasy spin column kit (Fisher Scientific, 
Pittsburgh, PA) and normalized concentrations were reverse transcribed, all as previously 
described (Lee et al., 2014). Quantitative real-time PCR was carried out using verified 
Taqman probes (Life Technologies, Grand Island, NY) for target or 18S on an ABI 7300 
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thermal cycler. Relative expression was determined using the ΔΔCt method and 18S as a 
housekeeping gene, with ABI 7300 and Excel software (Microsoft, Redmond, WA). 
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RESULTS 
Characterization of model 
The high fat diet rapidly altered the C57Bl6 hygiene, body weight, and glucose 
tolerance (Jackson Laboratory; Bar Harbor, ME). The mice exhibited oily skin in contrast 
to control counterparts, were more lethargic and retreated to the corners of their cages 
away from their cage-mates. The body weight of the mice fed the 60% kcal% fat diet was 
greater than the controls. The glucose tolerance test data obtained from Jackson 
Laboratory (Jackson Labs, Maine) revealed that after 8 weeks on the diet, the high fat 
diet caused increased blood glucose levels in these mice, suggesting a trend to impaired 
ability to metabolize glucose. By 26 wks of age (or 22 wks on the diet) there was a 
decrease in the DiO mouse’s capacity to process glucose (Jackson Lab data).  These 
demonstrate that the diet induced obesity model 
does simulate a pre-type II diabetic condition, 
where glucose digestion is impaired (Brownlee et 
al., 2005). Further characterization of the mouse 
model demonstrated no significant differences in 
the epithelial corneal thickness, but significant 
difference in the stroma between control and 
diabetic models (Figure 4). 
 
 
 
Figure 4: Control v. DiO Corneal Thickness  
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P2X7 Expression in Corneal Epithelium   
Immunohistochemical analysis of P2X7 in the intact and wounded corneal 
epithelium demonstrated striking changes in localization that occurred after injury 
between control and diabetic mice. P2X7 was detected in both control and diabetic mouse 
models at all three time points and was prominent at the leading edge of the migrated 
epithelium. In control mice, P2X7 was present at a greater intensity right at the tip of the 
leading edge closest to the wound, but decreased with increasing distance behind the 
leading edge. Among DIO corneas, however, P2X7 localization appeared to be more 
widespread or diffused throughout the epithelial tissue in comparison to their control 
counterparts and did not exhibit the same downregulation especially among the 15wk and 
22wk old mice (Figure 5a). The increase in widespread expression appeared to positively 
correlate with age of mouse and length of time spent on a high fat diet.  
  
Figure 5: Sustained P2X7 expression exhibited in DIO mice. Left column is control 
cornea, right column is diabetic cornea with rows separating the age of models analyzed. 
Wounds were made to the right of the epithelium displayed in the representative images 
and denoted by asterisks. Images were collected on Zeiss LSM 700 confocal microscope 
using a 40x oil objective on a 0.5 zoom. 
* 
* 
* 
* 
* 
* 
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To assess the change in intensity of P2X7 concentration at the wound edge 
compared with areas back from the wound, the wounded epithelium or migrating edge 
was divided into 5 regions of interest, each 40µm in length. The fluorescence area 
fraction ratio of each region of interest was measured using a thresholding technique and  
suggested higher intensity at the leading edge within the 0-40µm region in  both control 
8wk and 15wk mice in comparison to their DIO counterparts, although these results were 
not statistically significant  (Figure 5b).  This difference was not apparent in the 22wk 
models which exhibited similar threshold area percentage ratios within the regions closest 
to the leading edge among control and DIO models. However, when looking at the 22wk 
old mice, the ROIs of 120-160 µm and 160-200 µm back from the leading did exhibit 
significant statistical differences between control and DIO (P<0.01), agreeing with our 
initial observations of sustained intensity from the leading edge detected in our confocal 
images.  
To further quantify the difference in P2X7 localization behind the leading edge 
between the control and DIO models, a linear regression analysis comparing the slopes of 
intensity with increasing distance from the wound was performed. Both the 15wk and 
22wk old models demonstrated statistically significant differences in slope values 
(P<0.05) (Figure 5c). A significant difference was not found between control and DIO 
slopes among the 8wk old models. We hypothesize these results demonstrate age and 
length of time on the HFD do play a role in the demonstrated change in P2X7 localization 
and trafficking in response to wound healing. 
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Figure 6: Sustained P2X7 expression in DiO mice with increasing distance from 
Leading Edge of Wound. A: Graph of calculated average % area above threshold results 
from FIJI/ImageJ within 40µm interval ROIs among control and DIO samples for 8wk, 
15wk, and 22wk (n=3). Bars are ± standard error, with asteriks denoting statistically 
significant difference between control and DIO values within the ROI region. B: Graph 
of linear regression of % area above threshold using same data as (A). Dashed lines 
denote significantly different control slopes demonstrated in 15wk and 22wk old mice. 
Dotted lines surrounding linear regression lines are ± standard error with 95% 
confidence.  
A B 
A B 
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In Vivo/Ex Vivo P2X7 Gene Expression  
 
 Upon conclusion of our initial experiments characterizing localization of P2X7 
that demonstrated sustained intensity throughout the epithelial tissue rather than just at 
the leading edge in response to the wound, we decided to explore what we perceived to 
be a potential upregulation of the P2X7 purinergic receptor gene in response to a high fat 
diet. In Vivo P2X7 mRNA gene expression data was determined in corneas of control 
and DIO models where over a 10-fold difference in expression was found in those subject 
to HFD in comparison to their age matched control counterparts (Figure 7). 
 Ex vivo analysis of corneal tissue was also performed to compare the expression 
of P2X7 mRNA during wound healing under low versus high glucose environments. In 
these experiments corneal organ cultures were incubated for 12 hours postwounding and 
tissue from the wounded region and peripheral regions were evaluated for expression. 
Results were in agreement with those found in vivo with statistically significant higher 
expression found in a high glucose environment in both regions measured surrounding 
the wound area (Figure 8).  
Figure 7: In vivo data of P2X7 
mRNA. Over a 10-fold difference 
(11.193) in P2X7 mRNA expression 
was found in corneas of mice subject 
to HFD in comparison to their age 
matched control counterparts.  
Figure 8: Ex vivo data of P2X7 mRNA after 
12hr incubation period. Determinations were 
made for the wound and its surrounding 
peripheral area. Significantly higher expression 
was demonstrated in both areas when subject to 
a high glucose environment. 
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Qualification Analysis of Cis-Golgi  
 Lastly, we explored the potential difference in the cis-golgi apparatus between 
control and DIO models. Since the cis-golgi apparatus is the cell organelle responsible for 
protein trafficking and has been shown to play critical roles in GTPase signal 
transduction pathways at the leading edge of migrating cells, altered organelle polarity 
and expression could potentially provide rational for the altered P2X7 localization 
observed in diabetic models (Farhan & Hsu, 2016). Images were taken using the 
AIRyScan super resolution function of the Zeiss 880 Confocal Microscope. Qualitative 
analysis using the ZenLite 2.5D image analysis function demonstrated greater 
immunofluorescent signal emissions from the antibody tagged cis-golgi apparatus 
surrounding the nuclei of leading edge cells in the diabetic model (Figure 9). This 
suggests an upregulated response of the golgi-apparatus at the leading edge and a 
difference in organelle trafficking.  
  
Figure 9: Localization and intensity of GM130 is altered 15wks after high fat 
diet 12hr after corneal abrasion. Corneas were stained with GM130, an antibody 
to cis-golgi.  Localization was determined using a Zeiss 880 with AIRyScan (40x 
objective). Images are presented as 2.5D using a LUT intensity wedge to 
demonstrate the difference in the localization and  intensity of the GM130 in the 
DiO and control corneas. 
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DISCUSSION 
 
 Although the general importance of purinergic signaling to the early events of 
wound healing is established, the specific contributions made by different P2 receptors 
during this response are not well understood. Previous findings have suggested the P2X7 
receptor plays a pivotal role in promoting cell migration after corneal epithelial injury 
(Minns et al., 2016). Delayed corneal epithelial wound healing is present in a number of 
pathologies including diabetic keratopathy as a result of the diseases pathology (Fujita et 
al., 2003). Given this evidence, we aimed to explore the differences in P2X7 signaling 
and expression between control and DIO mouse models in order to establish potential 
rational for the delayed corneal epithelial wound healing observed in diabetic 
keratopathy. The DIO model represents a model for pre-type II diabetes.  
 Our control model results confirm previous findings that a complex change in 
P2X7 expression and localization occurs after corneal epithelial injury, with a marked 
increase in expression at the leading edge of the wound. The distinct P2X7 localization 
close to the leading edge as a result of injury has been thought to be due to the 
purinergics role in promoting rapid cytoskeletal rearrangements at the leading edge 
(Minns et al. 2016). The latter studies showed that inhibition of the P2X7 altered the 
features of the leading edge. The localization of P2X7 at the leading edge could also be 
attributed to the fact that it is an ion channel and it could be a sensor under control 
conditions. Given this localization was found to be less distinct and more widespread 
throughout the epithelial tissue behind the wound in DIO models that are subject to high 
fat diets, we hypothesize that the specific trafficking of the purinergic receptor may be 
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less efficient in diabetics (Figure 5). This hypothesis is strengthened by the fact that 
length of time spent on the high fat diet correlated with a more profound difference in the 
localization of P2X7 within the regions of interest behind the leading edge of the wound 
(Figure 6a & b).  
 Though localization may be altered in the DIO models, our in Vivo and ex Vivo 
analysis along with our qualitative results from our cis-golgi analysis suggest an 
upregulation in P2X7 expression. In fact the GM-130 is present throughout the 
epithelium and there is a lack of strict apical basal polarity around the cells. This 
significant upregulation found in high fat environment and in DIO models may suggest 
the cells are attempting to compensate for the lack of localization at the leading edge by 
enhancing expression of the receptor.  
Future Directions  
 Further analysis of the cis-golgi apparatus and its relation to purinergic signaling 
may provide further evidence of the differences observed between control and DIO 
models. Our experiment only depicted GM130 in the epithelium, but a duel-staining 
protocol for both cis-golgi and P2X7 may better characterize this trafficking relationship. 
It is worth mentioning that further analysis of cis-golgi polarity should be analyzed in 
future experiments, as previous findings have suggested altered polarity in cells to be 
characteristic of disease states and inefficient wound healing responses (Farhan & Hsu, 
2016). 
Another potential study could focus on the role of different purinergic receptors 
that exist in corneal tissue, such as P2X2 or P2X4, which may have similar functions as 
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P2X7. Analysis of the localization between these family members could potentially better 
characterize the differences demonstrated in purinergic wound healing response between 
control and DIO models.  
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